fluoxetine and valproic acid

fluoxetine has been researched along with valproic acid in 64 studies

Research

Studies (64)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	16 (25.00)	18.2507
2000's	15 (23.44)	29.6817
2010's	32 (50.00)	24.3611
2020's	1 (1.56)	2.80

Authors

Authors	Studies
Topliss, JG; Yoshida, F	1
Dansette, PM; Fontana, E; Poli, SM	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Abraham, MH; Acree, WE; Ibrahim, A	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM	1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ	1
Glen, RC; Lowe, R; Mitchell, JB	1
Ekins, S; Williams, AJ; Xu, JJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A	1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V	1
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T	1
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR	1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY	1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Jones, LH; Nadanaciva, S; Rana, P; Will, Y	1
Corrigan, FM	1
Davis, JM; Sovner, R	1
Cruz-Flores, S; Hayat, GR; Mirza, W	1
Deltito, JA	1
Baldessarini, RJ; Centorrino, F; Cohen, BM; Flood, JG; Huston-Lyons, D; Volpicelli, SA	1
Baldessarini, RJ; Centorrino, F; Flood, JG; Frankenburg, FR; Kando, J; Puopolo, PR; Volpicelli, SA	1
Fox, C; Sovner, R; Stone, A	1
Collins, DJ; Kmetz, GF; McElroy, SL	1
Calabrese, JR; Fatemi, SH; Rapport, DJ; Thuras, P	1
Brody, L; Damore, J; Stine, J	1
Berthier, ML; Blanco, E; Corrales, MA; Lucena, MI	1
Boerlin, HL; Gitlin, MJ; Hammen, CL; Zoellner, LA	1
Barringer, TM; Cavallaro, CA; Hubbell, CL; Mendez, JJ; Pabello, NG; Reid, LD	1
Coccaro, EF; Kavoussi, RJ	1
Mahendran, R	1
Bodak, A; Bodak, N; Droulers, A; Lefevre des Noettes, V; Oudjhani, M	1
Jaffe, R; Leavitt, R; Wind, T	1
Anagnostou, E; Chaplin, W; Esposito, K; Hollander, E; Soorya, L; Wasserman, S	1
Borowicz, KK; Czuczwar, SJ; Furmanek-Karwowska, K; Luszczki, JJ; Sawicka, K	1
Reimers, A; Skogvoll, E; Spigset, O; Sund, JK	1
Brenneman, DE; Crooke, JJ; Malatynska, E; Pinhasov, A; Smith-Swintosky, VL	1
Preskorn, SH	1
Ketter, TA	1
Calabrese, JR; Findling, RL; Ganocy, SJ; Gao, K; Kemp, DE; Muzina, DJ; Xia, G	1
Lim, YC	1
Fajutrao, L; Liu, S; Locklear, J; Paulsson, B	1
Beauclair, L; Desmarais, JE; Margolese, HC; Wolf, Y	1
Bain, EE; Bogers, W; Cannon, DM; Charney, DS; Drevets, WC; Henn, F; Manji, HK; Marrett, S; Neumeister, A; Nugent, AC; Roiser, JP; Savitz, JB; Zarate, CA	1
Fisar, Z; Hroudová, J; Raboch, J	1
Chinvarun, Y; Pinroj, Y; Ruangwittayawong, T; Saengpattrachai, M; Sithinamsuwan, P	1
Rushlow, WJ; Sutton, LP	1
Chou, KR; Chun Tsai, H; Hua Chang, H; Huang, SY; Hung Chi, M; Kuang Yang, Y; Lu, RB; See Chen, P; Tzeng, NS	1
Borowicz, KK; Czuczwar, SJ; Piskorska, B; Stępniak, B	1
Braitberg, G; Fisher, J; Graudins, A; Taori, G	1
Chang, YH; Chen, KC; Chen, PS; Chen, SL; Hong, JS; Huang, SY; Lee, IH; Lee, SY; Lu, RB; Tzeng, NS; Wang, CL; Wang, LJ; Wang, TY; Yang, YK	1
Cornelius, V; Smith, L; Taylor, DM; Young, AH	1
Citrome, L	1
Horn, ME; Luongo, FJ; Sohal, VS	1
Gold, PW; Goldstein, SA; Kling, MA; Licinio, J; Michelson, D; Mouro, CM; Pavlatou, MG; Wong, ML	1
Breen, EC; Coccaro, EF; Irwin, MR; Lee, R	1
Guan, LP; Liu, BY; Quan, YC; Wang, SH; Yang, LY; Zhen, XH	1
Kaushik, G; Thomas, MA; Xia, Y; Yang, L	1
Chaijaroonkhanarak, W; Chaisawang, P; Pannangrong, W; Prachaney, P; Sangrich, P; Sirichoat, A; Welbat, JU; Wigmore, P	1
Chang, HH; Chen, PS; Cheng, YW; Lu, RB; Wang, TY; Yang, YK	1
Fu, Z; Guan, L; Jiang, H; Jin, Q	1
Maaz, M; Naidoo, Y; Naufal, R; Tahir, R; Tahir, T; Wong, MM	1

Reviews

7 review(s) available for fluoxetine and valproic acid

Article	Year
Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity. Current drug metabolism, 2005, Volume: 6, Issue:5 Topics: Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Inhibitors; Humans; Isoenzymes; Structure-Activity Relationship; Terminology as Topic	2005
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Ring chromosome 22 and mood disorders. Journal of intellectual disability research : JIDR, 1996, Volume: 40 ( Pt 1) Topics: Adult; Anticonvulsants; Antidepressive Agents; Child; Chromosomes, Human, Pair 22; Drug Therapy, Combination; Female; Fluoxetine; Humans; Intellectual Disability; Male; Middle Aged; Mood Disorders; Ring Chromosomes; Valproic Acid	1996
Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder. The Journal of clinical psychiatry, 2008, Volume: 69 Suppl 5 Topics: Acute Disease; Affect; Anticonvulsants; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Lithium Carbonate; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Treatment Outcome; United States; United States Food and Drug Administration; Valproic Acid	2008
Comparative efficacy and acceptability of drug treatments for bipolar depression: a multiple-treatments meta-analysis. Acta psychiatrica Scandinavica, 2014, Volume: 130, Issue:6 Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Depression; Dibenzothiazepines; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lamotrigine; Lithium Compounds; Lurasidone Hydrochloride; Monoamine Oxidase Inhibitors; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Selective Serotonin Reuptake Inhibitors; Thiazoles; Treatment Outcome; Triazines; Valproic Acid	2014
Treatment of bipolar depression: making sensible decisions. CNS spectrums, 2014, Volume: 19 Suppl 1 Topics: Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Depressive Disorder, Major; Dibenzothiazepines; Drug Combinations; Drug Therapy, Combination; Fluoxetine; Humans; Isoindoles; Lithium Compounds; Lurasidone Hydrochloride; Quetiapine Fumarate; Thiazoles; Valproic Acid	2014
Pharmacotherapy of impulse control disorders: A systematic review. Psychiatry research, 2022, Volume: 311 Topics: Antidepressive Agents; Disruptive, Impulse Control, and Conduct Disorders; Fluoxetine; Humans; Valproic Acid	2022

Trials

8 trial(s) available for fluoxetine and valproic acid

Article	Year
Serum concentrations of clozapine and its major metabolites: effects of cotreatment with fluoxetine or valproate. The American journal of psychiatry, 1994, Volume: 151, Issue:1 Topics: Adult; Clozapine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Psychotic Disorders; Schizophrenia; Stimulation, Chemical; Valproic Acid	1994
Lamotrigine in rapid-cycling bipolar disorder. The Journal of clinical psychiatry, 1997, Volume: 58, Issue:12 Topics: Adult; Anticonvulsants; Bipolar Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lamotrigine; Lithium; Male; Middle Aged; Prospective Studies; Psychiatric Status Rating Scales; Regression Analysis; Treatment Outcome; Triazines; Valproic Acid	1997
Bipolar depression and antidepressant-induced mania: a naturalistic study. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:7 Topics: Adult; Ambulatory Care; Antidepressive Agents; Antidepressive Agents, Tricyclic; Bipolar Disorder; Carbamazepine; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Lithium; Male; Monoamine Oxidase Inhibitors; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Verapamil	1998
Divalproex sodium for impulsive aggressive behavior in patients with personality disorder. The Journal of clinical psychiatry, 1998, Volume: 59, Issue:12 Topics: Adult; Aggression; Anticonvulsants; Antimanic Agents; Female; Fluoxetine; Humans; Impulsive Behavior; Irritable Mood; Male; Middle Aged; Personality Disorders; Pilot Projects; Psychiatric Status Rating Scales; Psychotherapy; Treatment Outcome; Valproic Acid	1998
Divalproex versus placebo for the prevention of irritability associated with fluoxetine treatment in autism spectrum disorder. Journal of clinical psychopharmacology, 2006, Volume: 26, Issue:4 Topics: Antidepressive Agents, Second-Generation; Antimanic Agents; Autistic Disorder; Child; Double-Blind Method; Fluoxetine; Humans; Irritable Mood; Placebos; Treatment Outcome; Valproic Acid	2006
Effects of fluoxetine on the anticonvulsant action of valproate and ethosuximide in mouse model of myoclonic convulsions. Annals of agricultural and environmental medicine : AAEM, 2012, Volume: 19, Issue:3 Topics: Animals; Anticonvulsants; Antidepressive Agents, Second-Generation; Avoidance Learning; Convulsants; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Epilepsies, Myoclonic; Ethosuximide; Fluorescent Antibody Technique; Fluoxetine; Male; Memory, Long-Term; Mice; Motor Activity; Pentylenetetrazole; Seizures; Selective Serotonin Reuptake Inhibitors; Valproic Acid	2012
Correlation of plasma brain-derived neurotrophic factor and metabolic profiles in drug-naïve patients with bipolar II disorder after a twelve-week pharmacological intervention. Acta psychiatrica Scandinavica, 2015, Volume: 131, Issue:2 Topics: Adult; Affect; Bipolar Disorder; Body Mass Index; Brain-Derived Neurotrophic Factor; Cholesterol; Female; Fluoxetine; Humans; Linear Models; Lipoproteins, LDL; Longitudinal Studies; Lorazepam; Male; Metabolic Syndrome; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid	2015
Inflammatory markers and chronic exposure to fluoxetine, divalproex, and placebo in intermittent explosive disorder. Psychiatry research, 2015, Oct-30, Volume: 229, Issue:3 Topics: Adult; Aggression; Biomarkers; C-Reactive Protein; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Female; Fluoxetine; Humans; Inflammation Mediators; Interleukins; Irritable Mood; Male; Middle Aged; Psychotropic Drugs; Tumor Necrosis Factor-alpha; Valproic Acid	2015

Other Studies

49 other study(ies) available for fluoxetine and valproic acid

Article	Year
QSAR model for drug human oral bioavailability. Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13 Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship	2000
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs. European journal of medicinal chemistry, 2008, Volume: 43, Issue:3 Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization	2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models. Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3 Topics:	2008
Developing structure-activity relationships for the prediction of hepatotoxicity. Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes	2010
Predicting phospholipidosis using machine learning. Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5 Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine	2010
A predictive ligand-based Bayesian model for human drug-induced liver injury. Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12 Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands	2010
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites. Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:7 Topics: Glutathione; Pharmacology; Sulfur Radioisotopes	2011
FDA-approved drug labeling for the study of drug-induced liver injury. Drug discovery today, 2011, Volume: 16, Issue:15-16 Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration	2011
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets. Journal of medicinal chemistry, 2012, Jan-12, Volume: 55, Issue:1 Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics	2012
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions. Journal of medicinal chemistry, 2012, May-24, Volume: 55, Issue:10 Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection	2012
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds. Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10 Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding	2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships. Bioorganic & medicinal chemistry letters, 2016, 08-15, Volume: 26, Issue:16 Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone	2016
Sodium valproate augmentation of fluoxetine or fluvoxamine effects. Biological psychiatry, 1992, Jun-01, Volume: 31, Issue:11 Topics: Aged; Aged, 80 and over; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Valproic Acid	1992
A potential drug interaction between fluoxetine and valproic acid. Journal of clinical psychopharmacology, 1991, Volume: 11, Issue:6 Topics: Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Intellectual Disability; Middle Aged; Valproic Acid	1991
Valproic toxicity with fluoxetine therapy. Missouri medicine, 1995, Volume: 92, Issue:6 Topics: Adolescent; Age of Onset; Depressive Disorder; Dose-Response Relationship, Drug; Epilepsy, Generalized; Fluoxetine; Humans; Male; Temporal Lobe; Valproic Acid	1995
Valproate pretreatment for the difficult-to-treat patient with OCD. The Journal of clinical psychiatry, 1994, Volume: 55, Issue:11 Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Sertraline; Treatment Outcome; Valproic Acid	1994
Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 1993, Volume: 9, Issue:2 Topics: Animals; Brain; Clozapine; Fluoxetine; Half-Life; Male; Mass Spectrometry; Rats; Rats, Sprague-Dawley; Valproic Acid	1993
Response of kleptomania and mixed mania to valproate. The American journal of psychiatry, 1997, Volume: 154, Issue:4 Topics: Adult; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Comorbidity; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Fluoxetine; Humans; Valproic Acid	1997
Medication-induced hypomania in Asperger's disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 1998, Volume: 37, Issue:3 Topics: Antimanic Agents; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Bipolar Disorder; Child; Drug Therapy, Combination; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Valproic Acid	1998
Interaction of fluoxetine and valproic acid. The American journal of psychiatry, 1998, Volume: 155, Issue:4 Topics: Adult; Comorbidity; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Female; Fluoxetine; Humans; Seizures; Valproic Acid	1998
Responding for rewarding brain stimulation: cocaine and isradipine plus naltrexone. Pharmacology, biochemistry, and behavior, 1998, Volume: 61, Issue:2 Topics: Analysis of Variance; Animals; Brain; Calcium Channel Blockers; Cocaine-Related Disorders; Drug Therapy, Combination; Electric Stimulation; Fluoxetine; Isradipine; Male; Naltrexone; Narcotic Antagonists; Rats; Rats, Sprague-Dawley; Reward; Valproic Acid	1998
Obsessive-compulsive symptoms with risperidone. The Journal of clinical psychiatry, 1999, Volume: 60, Issue:4 Topics: Antipsychotic Agents; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Risk Factors; Risperidone; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Valproic Acid	1999
Decrease of valproic acid concentration in the blood when coprescribed with fluoxetine. Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:2 Topics: Aged; Aged, 80 and over; Anticonvulsants; Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Interactions; Epilepsy; Female; Fluoxetine; Humans; Valproic Acid	1997
QTc prolongation in multiple drug overdose. Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:3 Topics: Adult; Bupropion; Drug Overdose; Fluoxetine; Humans; Long QT Syndrome; Male; Piperazines; Psychotic Disorders; Thiazoles; Valproic Acid	2004
Chronically administered fluoxetine enhances the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model. European journal of pharmacology, 2007, Jul-12, Volume: 567, Issue:1-2 Topics: Animals; Anticonvulsants; Avoidance Learning; Brain; Carbamazepine; Drug Interactions; Drug Synergism; Electroshock; Fluoxetine; Male; Memory; Mice; Motor Activity; Phenobarbital; Phenytoin; Seizures; Selective Serotonin Reuptake Inhibitors; Valproic Acid	2007
Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions. European journal of clinical pharmacology, 2007, Volume: 63, Issue:7 Topics: Adolescent; Adult; Age Factors; Anticonvulsants; Antidepressive Agents; Benzodiazepines; Child; Child, Preschool; Contraceptives, Oral, Combined; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; Fluoxetine; Humans; Lamotrigine; Male; Models, Biological; Triazines; Valproic Acid	2007
Reduction of dominant or submissive behaviors as models for antimanic or antidepressant drug testing: technical considerations. Journal of neuroscience methods, 2007, Sep-30, Volume: 165, Issue:2 Topics: Animals; Antidepressive Agents; Antimanic Agents; Behavior, Animal; Bipolar Disorder; Data Interpretation, Statistical; Depressive Disorder; Disease Models, Animal; Dominance-Subordination; Drug Evaluation, Preclinical; Feeding Behavior; Fluoxetine; Neuropsychological Tests; Rats; Rats, Sprague-Dawley; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Social Behavior; Valproic Acid; Videotape Recording	2007
Deconstructing a medication regimen. Journal of psychiatric practice, 2008, Volume: 14, Issue:2 Topics: Adolescent; Antimanic Agents; Antipsychotic Agents; Benztropine; Biotransformation; Bipolar Disorder; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium Carbonate; Metabolic Clearance Rate; Ranitidine; Risperidone; Stupor; Valproic Acid	2008
Treatment-emergent mania/hypomania during antidepressant monotherapy in patients with rapid cycling bipolar disorder. Bipolar disorders, 2008, Volume: 10, Issue:8 Topics: Adult; Affect; Anticonvulsants; Antidepressive Agents, Second-Generation; Antimanic Agents; Bipolar Disorder; Comorbidity; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lamotrigine; Lithium Carbonate; Male; Middle Aged; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Selective Serotonin Reuptake Inhibitors; Substance-Related Disorders; Triazines; Valproic Acid	2008
Acute renal failure following detergent ingestion. Singapore medical journal, 2009, Volume: 50, Issue:7 Topics: Acetaminophen; Acute Kidney Injury; Adult; Depression; Detergents; Eating; Female; Fluoxetine; Humans; Treatment Outcome; Valproic Acid	2009
Cost-effectiveness of quetiapine plus mood stabilizers compared with mood stabilizers alone in the maintenance therapy of bipolar I disorder: results of a Markov model analysis. Clinical therapeutics, 2009, Volume: 31 Pt 1 Topics: Affect; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; Dibenzothiazepines; Double-Blind Method; Fluoxetine; Health Status; Humans; Markov Chains; Olanzapine; Quality-Adjusted Life Years; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Valproic Acid	2009
Loss of response after switching from brand name to generic formulations: three cases and a discussion of key clinical considerations when switching. International clinical psychopharmacology, 2010, Volume: 25, Issue:3 Topics: Drugs, Generic; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Secondary Prevention; Therapeutic Equivalency; Valproic Acid	2010
Habenula volume in bipolar disorder and major depressive disorder: a high-resolution magnetic resonance imaging study. Biological psychiatry, 2011, Feb-15, Volume: 69, Issue:4 Topics: Adult; Analysis of Variance; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Brain Mapping; Depressive Disorder, Major; Female; Fluoxetine; Habenula; Humans; Lithium Carbonate; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Valproic Acid	2011
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers. Neuro endocrinology letters, 2010, Volume: 31, Issue:5 Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride	2010
Kleine-Levin syndrome: the first typical case in Thailand. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2010, Volume: 93 Suppl 6 Topics: Adolescent; Adult; Diagnosis, Differential; Electroencephalography; Feeding and Eating Disorders; Female; Fluoxetine; Humans; Kleine-Levin Syndrome; Magnetic Resonance Imaging; Male; Treatment Outcome; Valproic Acid	2010
The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling. Neuroscience, 2011, Dec-29, Volume: 199 Topics: Animals; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; beta Catenin; Blotting, Western; Brain; Clozapine; Fluoxetine; Glycogen Synthase Kinase 3; Haloperidol; Imipramine; Immunoprecipitation; Lithium; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Valproic Acid	2011
The prevalence of metabolic syndrome in drug-naïve bipolar II disorder patients before and after twelve week pharmacological intervention. Journal of affective disorders, 2013, Mar-20, Volume: 146, Issue:1 Topics: Adult; Antimanic Agents; Bipolar Disorder; Body Mass Index; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Follow-Up Studies; Humans; Lorazepam; Male; Metabolic Syndrome; Prevalence; Treatment Outcome; Valproic Acid; Young Adult	2013
Methylene blue used in the treatment of refractory shock resulting from drug poisoning. Clinical toxicology (Philadelphia, Pa.), 2014, Volume: 52, Issue:1 Topics: Adult; Anticonvulsants; Antidepressive Agents, Second-Generation; Antidotes; Antipsychotic Agents; Blood Gas Analysis; Blood Pressure; Carbamazepine; Dibenzothiazepines; Electrocardiography; Fluid Therapy; Fluoxetine; Humans; Hypnotics and Sedatives; Hypotension; Male; Methylene Blue; Oxazepam; Quetiapine Fumarate; Shock; Valproic Acid; Vasoconstrictor Agents	2014
Putative Microcircuit-Level Substrates for Attention Are Disrupted in Mouse Models of Autism. Biological psychiatry, 2016, Apr-15, Volume: 79, Issue:8 Topics: Action Potentials; Animals; Attention; Autistic Disorder; Calcium; Disease Models, Animal; Fluoxetine; Fragile X Mental Retardation Protein; Mice, Inbred C57BL; Mice, Knockout; Nerve Tissue Proteins; Neural Pathways; Neurons; Prefrontal Cortex; Tissue Culture Techniques; Valproic Acid; Voltage-Sensitive Dye Imaging	2016
Chronic administration of anticonvulsants but not antidepressants impairs bone strength: clinical implications. Translational psychiatry, 2015, Jun-02, Volume: 5 Topics: Animals; Anticonvulsants; Antidepressive Agents; Bone and Bones; Bone Density; Carbamazepine; Femur; Fluoxetine; Imipramine; Male; Rats; Rats, Sprague-Dawley; Valproic Acid; X-Ray Microtomography	2015
Synthesis and Evaluation of Phenyliminoindolin-Containing Phenylacetamide Derivatives with the Antidepressant and Anticonvulsant Effects. Medicinal chemistry (Shariqah (United Arab Emirates)), 2016, Volume: 12, Issue:8 Topics: Acetanilides; Animals; Anticonvulsants; Antidepressive Agents; Dopamine; Electroshock; Fluoxetine; Hydroxyindoleacetic Acid; Indoles; Male; Mice; Norepinephrine; Seizures; Serotonin; Valproic Acid	2016
Psychoactive pharmaceuticals at environmental concentrations induce in vitro gene expression associated with neurological disorders. BMC genomics, 2016, 06-29, Volume: 17 Suppl 3 Topics: Animals; Autistic Disorder; Carbamazepine; Cell Line, Tumor; Environmental Pollutants; Fluoxetine; Gene Expression Profiling; Humans; Nervous System Diseases; Neuroblastoma; Psychotropic Drugs; Transcriptome; Valproic Acid; Venlafaxine Hydrochloride	2016
Fluoxetine prevents the memory deficits and reduction in hippocampal cell proliferation caused by valproic acid. Journal of chemical neuroanatomy, 2016, Volume: 78 Topics: Animals; Cell Proliferation; Doublecortin Protein; Fluoxetine; Hippocampus; Male; Memory Disorders; Neurons; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Spatial Memory; Valproic Acid	2016
FGF21 Is Associated with Metabolic Effects and Treatment Response in Depressed Bipolar II Disorder Patients Treated with Valproate. The international journal of neuropsychopharmacology, 2018, 04-01, Volume: 21, Issue:4 Topics: Adult; Antimanic Agents; Bipolar Disorder; Body Weight; Depressive Disorder, Major; Drug Therapy, Combination; Female; Fibroblast Growth Factors; Fluoxetine; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Valproic Acid; Waist Circumference; Young Adult	2018
Syntheses of Benzo[ Marine drugs, 2019, Jul-23, Volume: 17, Issue:7 Topics: Animals; Antarctic Regions; Anticonvulsants; Antidepressive Agents; Aquatic Organisms; Benzothiazoles; Biological Products; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Fluoxetine; Humans; Injections, Intraperitoneal; Male; Mice; Mice, Inbred ICR; Penicillium; Seizures; Stress, Psychological; Toxicity Tests; Treatment Outcome; Valproic Acid	2019